Provocation tests in diagnosing drug hypersensitivity

Current Pharmaceutical Design

Volumn 14, Issue 27, 2008, Pages 2792-2802

  Bousquet, Philippe Jean ^a,b   Gaeta, Francesco ^c,d   Bousquet Rouanet, Laure ^e   Lefrant, Jean Yves ^e   Demoly, Pascal ^b,f   Romano, Antonino ^c,g  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c Allergy Unit   (Italy)

^d IRCCS   (Italy)

^e Anesthésie Réanimation   (France)

^f INSERM   (France)

^g OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Challenges; Diagnosis; Drug allergy; Hypersensitivity; Provocation tests

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFATRIZINE; CEFAZOLIN; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOXACILLIN; DICLOFENAC; ERYTHROMYCIN; GLUCOCORTICOID; HEPARIN; IMMUNOGLOBULIN E; IODINATED CONTRAST MEDIUM; JOSAMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PARACETAMOL; PEFLOXACIN; ROXITHROMYCIN; SPIRAMYCIN; UNINDEXED DRUG;

ALLERGIC URTICARIA; ANGIONEUROTIC EDEMA; ASTHMA; ATOPY; CLINICAL PROTOCOL; CONJUNCTIVITIS; CROSS REACTION; DELAYED HYPERSENSITIVITY; DRUG ADMINISTRATION; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DYSPNEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION SITE ERYTHEMA; INTRACUTANEOUS TEST; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; PATCH TEST; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; RISK FACTOR; RISK REDUCTION; URTICARIA; VESICULAR RASH; WHEEZING;

ANIMALS; BRONCHIAL PROVOCATION TESTS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; EUROPE; HUMANS; PHARMACEUTICAL PREPARATIONS; PRACTICE GUIDELINES AS TOPIC; SKIN TESTS;

EID: 65949094364     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786369731     Document Type: Review

References (76)

1. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: General considerations. Allergy 2003; 58: 854-63.
2. Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004; 34: 1597-601.
3. Orhan F, Karakas T, Cakir M, Akkol N, Bahat E, Sonmez FM, et al. Parental-reported drug allergy in 6- to 9-yr-old urban school-children. Pediatr Allergy Immunol 2008; 19: 82-5.
4. Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol 2008; Jan 22.
5. Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity. Allergy 1999; 54: 999-1003.
6. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139: 683-93.
7. Romano A, Demoly P. Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol 2007; 7: 299-303.
8. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
9. Torres MJ, Blanca M, Fernandez J, Romano A, de Weck A, Aberer W, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58: 961-72.
10. Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K, et al. Diagnosis of nonimmediate reactions to β-lactam antibiotics. Allergy 2004; 59: 1153-60.
11. Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111: 913-21.
12. Stevenson DD, Simons RA, Zuraw BL. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Adkinson N, Yunginger J, Busse W, Bochner B, Holgate S, Simons F Eds, Middleton's allergy principles and practice. 6th ed, Philadephia, Mosby. 2003; 1695-710.
13. Wütschert R, Piletta P, Bounameaux H. Adverse skin reactions to low molecular weight heparins. Drug Saf 1999; 20: 515-25.
14. Padial A, Posadas S, Alvarez J, Torres MJ, Alvarez JA, Mayorga C, et al. Nonimmediate reactions to systemic corticosteroids suggest an immunological mechanism. Allergy 2005; 60: 665-70.
15. Davis C, Shearer WT. Diagnosis and management of HIV drug hypersensitivity. J Allergy Clin Immunol 2008; 121: 826-32.
16. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Świerczyńska M, Picado C, Scadding G, et al. EAACI/ GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62: 1111-8.
17. Muller UR, Haeberli G. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 2005; 115: 606-10
18. TenBrook JA Jr, Wolf MP, Hoffman SN, Rosenwasser LJ, Konstam MA, Salem DN, et al. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004; 113: 977-82.
19. Toogood JH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immun 1988; 81: 1-5.
20. Lieberman P, Kemp S, Oppenheimer JJ, Land I, Bernstein IL, Nicklas RA. The diagnosis and management of anaphylaxis: An update practice parameter. J Allergy Clin Immunol 2005; 115: S483-523.
21. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-7.
22. Solensky R. Drug allergy: Desensitization and treatment of reactions to antibiotics and aspirin. In: Lockley RF, Bukantz SC, Bousquet J Eds, Allergens and allergens immunotherapy for allergic diseases. 3rd edition, New-York, Marcel Dekker 2004; 585-606.
23. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140: 1001-6.
24. Co-Minh HB, Demoly P, Guillot B, Raison-Peiron N. Anaphylactic shock after oral intake and contact urticaria due to polyethylene glycols. Allergy 2007; 62: 92-3.
25. Bush R, Taylor S, Hefle S. Adverse reactions to food and drug additives. In: Adkinson N, Yunginger J, Busse W, Bochner B, Holgate S, Simons F Eds, Middelton's allergy principles and practice. 6th edition, Philadephia, Mosby 2003; 1645-63.
26. Greenberger PA. 8. Drug allergy. J Allergy Clin Immunol 2006; 117 (Suppl 2): S464-70.
27. Chandra RK, Joglekar SA, Tomas E. Penicillin allergy: Anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child 1980; 55: 857-60.
28. Blanca M, Torres MJ, García JJ, Romano A, Mayorga C, de Ramon E, et al. Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics. J Allergy Clin Immunol 1999; 103: 918-24.
29. Mendelson LM, Ressler C, Rosen JP, Selcow JE. Routine elective penicillin allergy skin testing in children and adolescents: Study of sensitization. J Allergy Clin Immunol 1984; 73: 76-81.
30. Parker PJ, Parrinello JT, Condemi JJ, Rosenfeld SI. Penicillin resensitization among hospitalized patients. J Allergy Clin Immunol 1991; 88: 213-7.
31. López-Serrano MC, Caballero MT, Barranco P, Martínez-Alzamora F. Booster responses in the study of allergic reactions to beta-lactam antibiotics. J Invest Allergol Clin Immunol 1996; 6: 30-5.
32. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: Reliability of examination assessed by skin testing and oral challenge. J Pediatr 1998; 132: 137-43.
33. Matheu V, Pérez-Rodriguez E, Sánchez-Machin I, García-Robaina JC, de la Torre Morin F. Importance of repeat testing in the diagnosis of penicillin allergy. Br J Dermatol 2006; 154: 198.
34. Goldberg A, Confino-Cohen R. Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy. Ann Allergy Asthma Immunol 2008; 100: 37-43.
35. Romano A, Guéant-Rodriguez RM, Viola M, Amoghly F, Gaeta F, Guéant, JL. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005; 35: 1234-42.
36. Torres MJ, Mayorga C, Leyva L, Guzman AE, Cornejo-García JA, Juarez C, et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy 2002; 32: 270-6.
37. Atanasković-Marković M, Veličković CT, Gavrović-Jankulović M, Vučković O, Nestorović B. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol 2005; 16: 341-7.
38. Romano A. Delayed hypersensitivity to aminopenicillins. Clin Exp Allergy 1998; 8 (Suppl 4): 29-32.
39. Romano A, Quaratino D, Di Fonso M, Papa G, Venuti A, Gasbarrini G. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol 1999; 103: 1186- 90.
40. Romano A, Di Fonso M, Pietrantonio F, Pocobelli D, Giannarini L, Del Bono A, et al. Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics. Contact Dermatitis 1993; 28: 190.
41. Patriarca G, Schiavino D, Nucera E, Milani A. Positive allergological tests may turn negative with no further exposure to the specific allergen: A long-term, prospective, follow-up study in patients allergic to penicillin. J Invest Allergol Clin Immunol 1996; 6: 162-5.
42. Torres MJ, Sánchez-Sabaté E, Álvarez J, Mayorga C, Fernández J, Padial A, et al. Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004; 59: 219-24.
43. Romano A, Viola M, Bousquet JP, Gaeta F, Valluzzi R, Caruso C, Demoly P. A comparison of the performance of two penicillin reagent kits in the diagnosis of β-lactam hypersensitivity. Allergy 2007; 62: 53-8
44. Romano A, Viola M, Mondino C, Pettinato R, Di Fonso M, Papa G, et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002; 129: 169-74.
45. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152: 968-74.
46. Aihara M, Ikezawa Z. Evaluation of the skin test reactions with delayed type rash induced by penicillins and cephalosporins. J Dermatol 1987; 14: 440-8.
47. Terrados S, Blanca M, García J, Vega J, Torres MJ, Carmona MJ, et al. Nonimmediate reactions to betalactams: Prevalence and role of the different penicillins. Allergy 1995; 50: 563-7.
48. Luque I, Leyva L, Torres MJ, Rosal M, Mayorga C, Segura JM, et al. In vitro T-cell responses to β-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001; 56: 611-8.
49. Padial A, Antunez C, Blanca-Lopez N, Fernandez TD, Cornejo-Garcia JA, Mayorga C, et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38: 822-8.
50. Romano A, Gaeta F, Valluzzi RL, Alonzi C, Viola M, Bousquet JP. Diagnosing hypersensitivity reactions to cephalosporins in children. Pediatrics, 2008 (in press).
51. Bierman CW, Pierson WE, Zeitz SJ, Hoffman Ls, VanArsdel PP Jr. Reactions associated with ampicillin therapy. JAMA 1972; 220: 1098-100.
52. Juhlin L, Ahlsedt S, Andal L, Ekström B, Svärd PO, Wide L. Antibody reactivity in penicillin-sensitive patients determined with different penicillin derivatives. Int Arch Allergy appl Immunol 1977; 54: 19-28.
53. Green GR, Rosenblum AH, Sweet LC. Evaluation of penicillin hypersensitivity: Value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. J Allergy Clin Immunol 1977; 60: 339-45.
54. Warrington RJ, Simons FER, Ho HW, Gorski BA, Tse KS. Diagnosis of penicillin allergy by skin testing: The Manitoba experience. Can Med Assoc J 1978; 118: 787-91.
55. Romano A, Quaratino D, Papa G, Di Fonso M, Venuti A. Amino-penicillin allergy. Arch Dis Child 1997; 76: 513-7.
56. Ponvert C, Le Clainche L, de Blic J, Le Bourgeois M, Scheinmann P, Paupe J. Allergy to β-lactam antibiotics in children. Pediatrics 1999; 104: E45.
57. Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 2008; 38: 185-90.
58. Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal anti-inflammatory drugs: Results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996; 98: 678- 85.
59. Schubert B, Perdekamp GMT, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. Nonsteroidal anti-inflammatory drug hypersensitivity: Fable or reality? Eur J Dermatol 2005; 15: 164-7.
60. Viola M, Quaratino D, Volpetti S, Gaeta F, Romano A. Parecoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 2006; 117: 1189-91.
61. Vieluf D, Przybilla B, Schwerbrock U, Ring J. Oral provocation test in the diagnosis of anaphylactoid reactions to 'mild' analgesic preparations. Int Arch Allergy Immunol 1995; 107: 268-71.
62. Kvedariene V, Bencherioua AM, Messaad D, Godard P, Bousquet J, Demoly P. The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: Results of a single-blinded trial. Clin Exp Allergy 2002; 32: 1366-9.
63. Boussetta K, Ponvert C, Karila C, Le Bourgeois M, de Blic J, Scheinmann P. Hypersensitivity reactions to paracetamol in children: A study of 25 cases. Allergy 2005; 60: 1174-7.
64. Lammintausta K, Kortekangas-Savolainen O. Oral challenge in patients with suspected cutaneous adverse drug reactions: Findings in 784 patients during a 25-year-period. Acta Derm Venereol 2005; 85: 91-6
65. Quiralte J, Blanco C, Delgado J, Ortega N, Alcántara M, Castillo R, et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Invest Allergol Clin Immunol 2007; 17: 182-8.
66. Viola M, Quaratino D, Gaeta F, Valluzzi RL, Caruso C, Rumi G, et al. Allergic reactions to antibiotics, mainly betalactams: Facts and controversies. Eur Ann Allergy Asthma Clin Immunol 2005; 37: 223-9.
67. Benahmed S, Scaramuzza C, Messaad D, Sahla H, Demoly P. The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single blinded trial. Allergy 2004; 59: 1130- 3.
68. Scheuer E., Warshaw E. Allergy to corticosteroids: Update and review of epidemiology, clinical characteristics and structural cross-reactivity. Am J Contact Dermat 2003; 14: 179-87.
69. Koch P, Münssinger T, Rupp-John C, Uhl K. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractioned and low-molecular weight heparins: Tolerance of a new recombinant hirudins. J Am Acad Dermatol 2000; 42: 612-9.
70. Bircher AJ, Harr T, Hohenstein L, Tsakiris DA. Hypersensitivity reactions to anticoagulant drugs: Diagnosis and management options. Allergy 2006; 61: 1432-40.
71. Gaigl Z, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: A prospective study. Br J Haematol 2005; 128: 389- 92.
72. Yocum MW, Heller AM, Abels RI. Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media-sensitive patients. J Allergy Clin Immunol 1978; 62: 309-13.
73. Vernassiere C, Trechot P, Commun N, Schmutz JL, Barbaud A. Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis 2004; 50: 359-66.
74. Colombo G, Terzano C, Colombo P, Petroianni A, Ricci A, Buttini F. Methacholine dry powder inhaler as a new tool for bronchial challenge test. Int J Pharm 2008; 352(1-2): 165-71.
75. Fukunaga H, Ohkubo T, Kobayashi M, Tamaki Y, Kikuya M, Obara T, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. J Hypertens 2008; 26(4): 685-90.
76. Koh Y, Yap CW, Li SC. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system. Int J Med Inform 2008; 77(6): 421-30.